This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
The Zacks Analyst Blog Highlights: Meritage Homes, Sarepta Therapeutics, The Clorox Company, The Hain Celestial Group and Entergy
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Meritage Homes, Sarepta Therapeutics, The Clorox Company, The Hain Celestial Group and Entergy
Any Bright Spot in Q1 Earnings? Sector ETFs & Stocks to Buy
by Sweta Killa
First-quarter results are likely to be bleak, given that the coronavirus outbreak are weighing on corporate profits. However, there are still some bright spots. Let's have a look.
5 Stocks to Win Big This Brutal Q1 Earnings Season
by Tirthankar Chakraborty
There are certain sectors whose earnings are expected to perk up in the first quarter despite this pandemic. Such sectors include Construction, Medical, Consumer Staples and Utilities.
Why Meritage (MTH) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Meritage (MTH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
D.R. Horton's Q2 Sales Strong, March Cancellation Rate Rises
by Zacks Equity Research
Although D.R. Horton (DHI) reports strong Q2 orders, its March cancellation rate rises due to coronavirus pandemic.
Meritage Homes' (MTH) Q1 Orders Strong, March Orders Decline
by Zacks Equity Research
Although Meritage Homes (MTH) reports strong Q1 orders, its March orders decline due to coronavirus pandemic.
5 Low P/CF Stocks for a Solid Portfolio Amid Coronavirus Crisis
by Sumit Singh
Investment in stocks made on diligent value analysis is usually considered one of the best practices. In value investing, investors pick stocks that are cheap but fundamentally sound.
The Zacks Analyst Blog Highlights: D.R. Horton, Meritage Homes, TRI Pointe, Century Communities and M.D.C.
by Zacks Equity Research
The Zacks Analyst Blog Highlights: D.R. Horton, Meritage Homes, TRI Pointe, Century Communities and M.D.C.
Coronavirus Risks Rife for Housing: What Does Spring Market Hold?
by Shrabana Mukherjee
The U.S. housing market is expected to be hurt by coronavirus-induced recession and layoffs. Will the ongoing spring season bring some relief?
Top Ranked Value Stocks to Buy for April 2nd
by Zacks Equity Research
Here are four stocks with buy rank and strong value characteristics for investors to consider today, April 2nd
Are Investors Undervaluing Meritage Homes (MTH) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
RPM's Q3 Results to be at Higher End of Previous Guidance
by Zacks Equity Research
RPM's third-quarter fiscal 2020 results are likely to be at the higher end of its prior view owing to strong restructuring initiatives.
Lennar (LEN) Earnings and Revenues Beat in Q1, Shares Rise
by Zacks Equity Research
Benefits from higher operating leverage and rising demand help Lennar (LEN) post better-than-expected fiscal Q1 earnings. However, it suspends guidance owing to the coronavirus crisis.
Housing Starts Drop in February, Coronavirus a Potent Threat
by Ankita Gupta
The housing space struggles to surge as COVID-19 disrupts world economy. Also, housing starts and building permits decline in March.
Builders Sentiments Slip in March as Coronavirus Fears Rise
by Zacks Equity Research
Builders sentiments slip two points low in March as coronavirus spreads across the United States.
Is Meritage Homes (MTH) a Great Stock for Value Investors?
by Zacks Equity Research
Let's see if Meritage Homes Corporation (MTH) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
The Zacks Analyst Blog Highlights: PulteGroup, Meritage Homes, Lennar, M.D.C. and D.R. Horton
by Zacks Equity Research
The Zacks Analyst Blog Highlights: PulteGroup, Meritage Homes, Lennar, M.D.C. and D.R. Horton
Top Ranked Growth Stocks to Buy for March 10th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, March 10th
Are Investors Undervaluing Meritage Homes (MTH) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Can Home Builders Continue to Thrive Amid Coronavirus Threat?
by Nalak Das
A stable U.S. economy and record low market interest rate, which resulted in sharp decline in mortgage rate, primary catalysts driving the industry.
What Fed's Hasty Rate Cut Means for Housing Amid Corona Scare
by Shrabana Mukherjee
Lower mortgage rates resulting from the Fed rate cut will likely help housing sustain momentum.
Why Is Meritage (MTH) Down 10.9% Since Last Earnings Report?
by Zacks Equity Research
Meritage (MTH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Zacks Analyst Blog Highlights: Toll Brothers, D.R. Horton, PulteGroup, KB Home and Meritage Homes
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Toll Brothers, D.R. Horton, PulteGroup, KB Home and Meritage Homes
New Home Sales Touch 13-Year High: 5 Stocks to Invest In
by Ankita Gupta
Despite supply woes, new home sales hit the highest level in January since July 2007 on the back of strong housing market fundamentals.
Is Meritage Homes (MTH) Stock Outpacing Its Construction Peers This Year?
by Zacks Equity Research
Is (MTH) Outperforming Other Construction Stocks This Year?